Thrombosis Journal

The endogenous hypercortisolism that characterizes Cushing’s syndrome (CS) is associated with a state of hypercoagulability that significantly increases the risk of thromboembolic disease, especially, venous events. Despite this certainty, there is no consensus on the best thromboprophylaxis strategy (TPS) for these patients. The aim of this article is to summarize the published data about different thromboprophylaxis strategies, and to review available clinical tools assisting thromboprophylaxis decision making.

Read more

“It is with great pleasure that I join the Editorial team of Thrombosis Journal and to take on the role as co-Editor-in-Chief (EiC). This is indeed a great honor for me. For your information, I am a biochemist and have been active in the field of Thrombosis and Haemostasis with a particular interest in fibrinolysis for over 38 years. I am looking forward to making a positive contribution to Thrombosis Journal. I would very much like to thank and acknowledge the many years at the helm by my predecessor Prof Hugo Ten Cate. I will do my best to fill Hugo’s shoes. I would also like to acknowledge the long-lasting role of Yukio Ozaki as co-EiC who will be continuing in this role. I am looking forward to working with Prof Ozaki and the dedicated Associate Editors to develop and implement new ideas and approaches to improve the standing of the Journal.”

                                            Robert Medcalf, Editor-in-Chief, Thrombosis Journal